| Systemic inflammation as a confounding factor in cancer biomarker discovery and validation M Chechlinska, M Kowalewska, R Nowak Nature Reviews Cancer 10 (1), 2-3, 2010 | 188 | 2010 |
| Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis: M … J Kaminska, M Kowalska, B Kotowicz, M Fuksiewicz, M Glogowski, ... Oncology 70 (2), 115-125, 2006 | 172 | 2006 |
| Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I–an independent prognostic factor J Kaminska, MP Nowacki, M Kowalska, A Rysinska, M Chwalinski, ... Tumor biology 26 (4), 186-194, 2005 | 135 | 2005 |
| The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes M Kowalewska, M Chechlińska, S Markowicz, P Kober, R Nowak European Journal of Cancer 42 (16), 2671-2674, 2006 | 68 | 2006 |
| Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection M Sromek, M Glogowski, M Chechlinska, M Kulinczak, L Szafron, ... Cellular Oncology 40, 529-536, 2017 | 63 | 2017 |
| A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration G Rymkiewicz, B Grygalewicz, M Chechlinska, K Blachnio, ... Modern Pathology 31 (5), 732-743, 2018 | 59 | 2018 |
| Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia JL Perfettini, R Nardacci, M Bourouba, F Subra, L Gros, C Séror, G Manic, ... PLoS One 3 (6), e2458, 2008 | 45 | 2008 |
| Implications of cancer-associated systemic inflammation for biomarker studies M Kowalewska, R Nowak, M Chechlinska Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 163-171, 2010 | 42 | 2010 |
| Sera of lung cancer patients affect the release of Th1, Th2 and monocyte-derived cytokines, and the expression of IL-2Ralpha by normal, stimulated mononuclear cells M Chechlinska, A Duma, K Swierkowska, J Kaminska, J Steffen Cellular and Molecular Biology Letters 9 (1), 69-82, 2004 | 39 | 2004 |
| microRNAs in uterine sarcomas and mixed epithelial–mesenchymal uterine tumors: a preliminary report M Kowalewska, E Bakula-Zalewska, M Chechlinska, K Goryca, ... Tumor Biology 34, 2153-2160, 2013 | 37 | 2013 |
| The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients B Kotowicz, M Fuksiewicz, M Kowalska, J Jonska-Gmyrek, M Bidzinski, ... International Journal of Gynecologic Cancer 18 (6), 2008 | 35 | 2008 |
| Tumor and cerebrospinal fluid microRNAs in primary central nervous system lymphomas M Zajdel, G Rymkiewicz, M Sromek, M Cieslikowska, P Swoboda, ... Cancers 11 (11), 1647, 2019 | 25 | 2019 |
| Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma M Chechlinska, M Kowalewska, E Brzoska-Wojtowicz, J Radziszewski, ... Tumor Biology 31, 559-567, 2010 | 25 | 2010 |
| Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal M Chechlinska, JK Siwicki, M Gos, M Oczko-Wojciechowska, M Jarzab, ... BMC genomics 10, 1-15, 2009 | 25 | 2009 |
| Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications J Przybyl, K Kozak, H Kosela, S Falkowski, T Switaj, I Lugowska, ... Medical Oncology 31, 1-13, 2014 | 24 | 2014 |
| Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer M Fuksiewicz, M Kowalska, B Kotowicz, M Rubach, M Chechlinska, ... Clinical chemistry and laboratory medicine 48 (10), 1481-1486, 2010 | 22 | 2010 |
| Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination M Chechlinska, J Kaminska, J Markowska, A Kramar, J Steffen The International journal of biological markers 22 (3), 172-180, 2007 | 21 | 2007 |
| Genes, pathways and vulvar carcinoma-New insights from next-generation sequencing studies S Zięba, M Chechlińska, A Kowalik, M Kowalewska Gynecologic Oncology 158 (2), 498-506, 2020 | 20 | 2020 |
| miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B–cell lymphoma M Zajdel, G Rymkiewicz, M Chechlinska, K Blachnio, B Pienkowska-Grela, ... Tumor Biology 36 (7), 5377-5388, 2015 | 20 | 2015 |
| Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: are we aware of what we are detecting by mRNA examination? M Kowalewska, M Chechlinska, R Nowak British journal of cancer 98 (2), 512-513, 2008 | 20 | 2008 |
